Millennium Management’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$347K Buy
+1,052,334
New +$347K ﹤0.01% 3519
2024
Q3
Sell
-78,024
Closed -$60K 4351
2024
Q2
$60K Sell
78,024
-67,941
-47% -$52.3K ﹤0.01% 3767
2024
Q1
$445K Buy
+145,965
New +$445K ﹤0.01% 3345
2023
Q2
Sell
-272,916
Closed -$704K 4602
2023
Q1
$704K Buy
272,916
+131,212
+93% +$338K ﹤0.01% 3264
2022
Q4
$264K Sell
141,704
-88,460
-38% -$165K ﹤0.01% 3966
2022
Q3
$424K Sell
230,164
-14,046
-6% -$25.9K ﹤0.01% 3962
2022
Q2
$525K Sell
244,210
-207,856
-46% -$447K ﹤0.01% 3851
2022
Q1
$1.42M Buy
452,066
+66,299
+17% +$208K ﹤0.01% 3310
2021
Q4
$1.24M Sell
385,767
-27,124
-7% -$87K ﹤0.01% 3318
2021
Q3
$1.39M Sell
412,891
-352,759
-46% -$1.19M ﹤0.01% 3358
2021
Q2
$2.99M Buy
+765,650
New +$2.99M ﹤0.01% 2712
2021
Q1
Sell
-254,046
Closed -$587K 4796
2020
Q4
$587K Buy
254,046
+217,739
+600% +$503K ﹤0.01% 3150
2020
Q3
$208 Sell
36,307
-486,289
-93% -$2.79K ﹤0.01% 3235
2020
Q2
$3.85M Buy
522,596
+123,638
+31% +$911K 0.01% 1590
2020
Q1
$1.19M Buy
398,958
+79,121
+25% +$236K ﹤0.01% 1900
2019
Q4
$1.33M Buy
319,837
+218,876
+217% +$908K ﹤0.01% 2321
2019
Q3
$327K Sell
100,961
-247,014
-71% -$800K ﹤0.01% 2909
2019
Q2
$644K Buy
+347,975
New +$644K ﹤0.01% 2602
2019
Q1
Sell
-22,286
Closed -$54K 3642
2018
Q4
$54K Sell
22,286
-68,947
-76% -$167K ﹤0.01% 3220
2018
Q3
$517K Buy
91,233
+76,153
+505% +$432K ﹤0.01% 2873
2018
Q2
$118K Sell
15,080
-44,264
-75% -$346K ﹤0.01% 3256
2018
Q1
$420K Buy
+59,344
New +$420K ﹤0.01% 2847
2017
Q3
Sell
-18,443
Closed -$193K 3443
2017
Q2
$193K Buy
+18,443
New +$193K ﹤0.01% 2964